Document is current
Any future updates will be listed below
-
Authors
Mao, Lin
Ou, Yangjing
Zhang, Yuchao
Wang, Minghui
Dong, Guoqing
Khanniche, Asma
Wang, Hailong
Wu, Zhenchuan
Zhang, Haibing
Hu, Landian
Kong, Xiangyin
-
Funding
Funding for this research was provided by:
the National Key Research and Development Program of China (2022YFA080730)
the National Key Research and Development Program of China (2021YFA080521)
the Global Common Challenges Project of the Chinese Academy of Sciences (176GJHZ2023038GC)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2025ZD0552310)
- License Information
-
More Information
Article History
Received: 19 August 2025
Accepted: 25 February 2026
First Online: 17 March 2026
Declarations
:
: LDH and XYK are founders and scientific advisors of ANDA Biology Medicine Development (Beijing) Co., Ltd. A related patent application is pending. Other authors declare no conflicts.
: This study had accepted the ethics approval. For detailed information, please refer to the sections on “Materials and Methods”.
: We support inclusive, diverse, and equitable conduct of research.
